ANI Pharmaceuticals reported $5.44M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
AbbVie USD 700M 90M Mar/2025
ANI Pharmaceuticals USD 5.44M 46K Jun/2025
Aurora Cannabis CAD 1.78M 491K Jun/2025
Canopy Growth CAD 9.74M 7.03M Jun/2025
Eli Lilly USD 249M 5.3M Jun/2025
Hikma Pharmaceutical 22M 9M Jun/2024
Knight Therapeutics CAD 1.91M 369K Sep/2024
Novartis USD 289M 14M Jun/2025
Perrigo 39.6M 600K Jun/2025
Sun Pharmaceuticals 748M 256.6M Jun/2025
Teva Pharmaceutical Industries USD 252M 40M Jun/2025